GUIA DE SEGUIMIENTO FARMACOTERAPEUTICO SOBRE DIABETES PDF

que la mortalidad a largo plazo esté relacionada sobre todo con la recidiva de la enfermedad actuaciones en una guía de seguimiento del paciente trasplantado. . documento recoge recomendaciones farmacoterapéuticas, de autocuidado, de . de las guías. • Algunos pacientes pueden comenzar con una diabetes de. Efectividad del seguimiento farmacoterapéutico en diabéticos tipo 2 clínica, se obtuvo información sobre medicamentos antidiabéticos utilizados, dosis, .. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2. Objetivos: Realizar un seguimiento farmacoterapéutico y educar a pacientes conocimiento sobre la menopausia y la THR en pacientes menopaúsicas. Keywords: Hormone . ministerial que generará Guías Clínicas y tratará . stock de éste por el laboratorio que los produce. Diabetes. 38%. Depresión.

Author: Kejinn Mezinos
Country: Senegal
Language: English (Spanish)
Genre: Spiritual
Published (Last): 20 March 2018
Pages: 166
PDF File Size: 16.75 Mb
ePub File Size: 2.76 Mb
ISBN: 886-1-24351-771-7
Downloads: 75467
Price: Free* [*Free Regsitration Required]
Uploader: Togore

The study was conveniently conducted in these cities because there was trained personnel farmacoterqpeutico said purpose. The main reasons for this are:. Evaluation of risk factors for development of complications in Type II diabetes in Europe.

Universidad de Granada Grupo de Investigación en Atención Farmacéutica [WorldCat Identities]

In order to ensure patient safety as a component of quality of care 7Pharmaceutical Care Practice PCP must be conducted as a clinical activity rarmacoterapeutico Pharmaceutical Care PCwith the diagetes of reducing the morbimortality associated with the use of medications, through activities performed by the Pharmacist, who will diabetse responsible for identifying the needs of the patient regarding pharmacological treatment, with the aim to achieve results that will improve the quality of life of patients, working together with the healthcare team in order to make decisions about the treatment initiated, to ensure its safety and efficacy 8.

In Barranquilla, the prevalence of CKD is of approximately 46 persons perinhabitants 1. The primary etiology in all CKD patients appears in Figure 1.

  LAS METAMORFOSIS DE OVIDIO ANAYA PDF

There will be an increasing number of persons with CKD who will need to undergo treatments with side effects at short, medium and long term 5.

Universidad de Granada Grupo de Investigación en Atención Farmacéutica

Upon changes in medication, a new condition status was established, which also evaluated the acceptance or non-acceptance of the physician’s pharmaceutical recommendations. Diabetes in the Americas. The greatest number of NOM was identified for antidiabetic medications with cases for metformin Med Clin North Am.

Rev Cubana Farm ; 41 2 farmaciterapeutico This was followed by Group A, Alimentary Tract, and B, Blood and blood forming organs, because there must be prevention and treatment for metabolic alterations such as guiaa and anaemia, among others 24 – Cost of diabetes mellitus in Spain. Table 2 shows the NOM identified, with those relating to effectiveness being the most frequent On the other hand, hypertension and DM are the most important risk factors that lead to deterioration in renal function, because the kidney is one of the target organs in these conditions; at the same time, together they will increase the cardiovascular risk 22 This is an open-access article distributed under the terms of the Creative Commons Attribution License.

The loss of A descriptive analysis was performed of the cost variable for each of the EPSs and in each of the groups.

Seguimiento farmacoterapéutico en pacientes con insuficiencia renal crónica

Regarding age groups, 8 patients were in the toyear-old range, 18 patients were in the toyear-old range, and 21 patients were classified in the toyear-old group. El cociente medio del costo por paciente en el grupo control fue 1.

Diabetic patients do not adequately adhere to pharmacological or nutritional treatment, or to the recommended physical activity, which are required to reach a suitable metabolic control, leading to the emergence of micro and macrovascular complications 4. Direct health care costs of diabetic patients in Spain.

  LT141X7 124 PDF

It must be stated that the pharmacotherapeutic monitoring was carried out by the drug dispensing entity and not by the healthcare provider, for this reason the cost was not charged to the direct costs of patient xiabetes.

The study had a sample of patients 64 intervened and 79 controls with female predominance We observed an average of 6.

Rev Asoc Latinoam Diabetes. After the intervention, the number of DRPs was reduced to 9 in 8 patients in total, which means spbre 22 patients did not present DRPs again, and Initial HbA1c mean was 7.

March 10, ; Accepted: Necessity NOMs showed that not all the health problems are being treated in these patients; that is to say, only their basal disease was controlled, while the problems caused by it were being overlooked. The medications with one single case were clobazam, ceftriaxone and dexamethasone.

Given that different studies have not been able to show the efficacy of pharmacotherapeutic monitoring to better control the disease and even reduce healthcare costs, we suggest the need farmacotefapeutico said intervention to aid in optimizing the benefits in healthcare services for patients with chronic treatments. During the study, the patients were visited on at least three instances, establishing the NOMs in each visit. It is worth mentioning that farmacoterapeuticl the study carried out, there was an important loss of patients